Mark Clements, a Professor, Pediatric Endocrinologist, and Project Lead at Rising T1DE Alliance, serves as Chief Medical Officer at Glooko with a focus on research. He chairs the Type 1 Diabetes Exchange Clinic Registry, co-leads data science for the Type 1 Diabetes Exchange Quality Improvement Collaborative, and leads clinical trials in type 1 diabetes. Mark Clements leads innovative projects using advanced machine learning to predict diabetes outcomes and improve care. He also became Chief Medical Officer of Glooko, Inc. in May 2019.